CaloSense

CaloSense operates a medical weight-loss support program aimed at people using GLP-1 medications or recovering from bariatric surgery. The program combines connected smart devices, AI-generated insights and dedicated human case managers to track patient progress and support adherence over time. It is positioned as a remote patient monitoring platform for severe obesity.

Patients enrolled in the program receive monthly physician oversight together with daily support from an assigned personal case manager, with care delivered according to established medical guidelines. The stated objective is to help patients maintain results beyond the initial response period to treatment, work through weight-loss plateaus and reduce weight regain. The company distributes a consumer-facing Android application in the Health & Fitness category, which handles onboarding and collects personal and health and fitness data, encrypted in transit.

Business model

CaloSense delivers an ongoing clinical support service wrapped around GLP-1 and bariatric care, pairing smart devices and software with staffed case management and physician oversight. The company states the program is covered by most major insurance plans, indicating reimbursement through payers rather than direct patient payment.

The company states its program is fully covered by most major insurance plans, pointing to payer reimbursement for the monitoring and case-management service.

Traction

The Android application has surpassed 100 downloads on Google Play and continues to receive maintenance releases, including onboarding bug fixes noted in an update dated June 2026.